Zimmer Biomet received an additional FDA 510(k) clearance for the Persona® Revision Knee. Initial U.S. launch will commence in coming weeks; full launch is slated for 2020. This revision model completes the company's portfolio of Persona patient-personalized designs. Persona Revision received its first 510(k) clearance in 4Q18.
Persona Revision features Zimmer Biomet's Trabecular Metal™ porous biomaterial and the Vivacit-E® Highly Crosslinked Polyethylene (HXPE) bearing surface. Persona knees are compatible with the company's ROSA® Knee robot, along with Vanguard® and NexGen® systems.
"Persona Revision completes Zimmer Biomet's flagship Persona knee system and enhances our ecosystem of customer-centric solutions that address the needs of our customers and improve patient outcomes," said Ivan Tornos, Zimmer Biomet's Group President of Global Orthopedics. "The highly-anticipated release of Persona Revision provides surgeons with a full portfolio for the continuum of knee arthroplasty care and the ability to truly tailor an implant solution based on each patient's unique requirements."
Source: Zimmer Biomet, Inc.